NBIX vs NVTS · P/E 45, rev $1.77B vs rev $19.1M
Neurocrine Biosciences Inc (NBIX) versus Navitas Semiconductor Corp (NVTS) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Navitas Semiconductor Corp (NVTS) is a semiconductors company listed on NASDAQ.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported NVTS revenue for 2026-06-30 was $19.1M. Net income was -$262.0M. NVTS currently screens at market cap $5.60B.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. NVTS currently screens at market cap $5.60B.
Not investment advice. Open the NBIX and NVTS stock pages for the full models.
Not investment advice.